Innovating Works

BIOBAM BIOINFORMATICS SL

Activa
ENTRY-DM: Interdisciplinary doctoral training on oligonucleotide based therapies for myotonic dystrophy Rare diseases, though individually infrequent, collectively pose important challenges for patients, clinicians and researchers in terms of d...
2024-06-28 - 2029-02-28 | Financiado
LongTREC: Long TREC The Long Reads Transcriptomics European Consortium. The next generation transcriptome bio... AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Thrid-generation, single-molecule long-read sequencing technologies such as Nanopore and Pacbio are revolutionizing transcriptome research a...
2022-07-14 - 2026-09-30 | Financiado
INTERCEPT-MDS: Exploring cell to cell heterogeneity and exploiting epigenetic regulation for the interception of my... FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS tramitó un H2020: H2020-MSCA-ITN-2020 Disease interception is a novel concept referring to treatment of a disease before the disease fully develops by removing altered cells. To...
2020-08-13 - 2024-12-31 | Financiado
ChroMe: Chromatin and Metabolism Chromatin metabolism interactions as targets for healthy living LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN tramitó un H2020: H2020-MSCA-ITN-2015 Metabolic disorders are at pandemic levels. Based on recent estimates, ~50% of Europeans are overweight, 20% are obese and 10% have type II...
2016-04-05 - 2020-02-29 | Financiado
DEANN: Developing an European American NGS Network Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe tramitó un FP7: The DEANN project is a network formation initiative that involves six research institutions and universities from four EU countries and equi...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.